Profil
Eric Meldrum is currently the Chief Scientific Officer at ENYO Pharma SA and Citryll BV.
He previously held the position of Chief Scientific Officer at Calliditas Therapeutics Suisse SA.
Postes actifs de Eric Meldrum
| Sociétés | Poste | Début |
|---|---|---|
Citryll BV
Citryll BV Miscellaneous Commercial ServicesCommercial Services Engages in development of therapeutic products to treat autoimmune and other human diseases | Directeur Technique/Scientifique/R&D | 29/08/2023 |
ENYO Pharma SA
ENYO Pharma SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Eric Meldrum
| Sociétés | Poste | Fin |
|---|---|---|
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Develops small molecule therapeutics that selectively inhibit NOX enzymes | Directeur Technique/Scientifique/R&D | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Develops small molecule therapeutics that selectively inhibit NOX enzymes | Health Technology |
ENYO Pharma SA
ENYO Pharma SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Citryll BV
Citryll BV Miscellaneous Commercial ServicesCommercial Services Engages in development of therapeutic products to treat autoimmune and other human diseases | Commercial Services |
















